Get started
Author

Charles T. Gregory

Observed names: C. Thomas Gregory, Charles Gregory, Charles Thomas Gregory, Gregory, Charles, Gregory, Charles Thomas, Thomas Gregory
ORCID: 0000-0001-9357-369X
Observed ORCID: 0000-0001-9357-369X
OpenAlex ID: A5071502547
Myc Regulates Chromatin Decompaction and Nuclear Architecture during B Cell Activation
2017 · Kyong-Rim Kieffer-Kwon, Keisuke Nimura, et al. · Molecular Cell · 205
PDF
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations
2020 · Fabienne Lucas, Karylin Larkin, et al. · Blood · 63
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia
2022 · Steven Sher, Ethan Whipp, et al. · Leukemia · 37
PDF
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
2023 · Zachary A. Hing, Janek S. Walker, et al. · Nature Communications · 31
PDF
Characterization and mitigation of fragmentation enzyme-induced dual stranded artifacts
2020 · Thomas Gregory, Apollinaire Ngankeu, et al. · NAR Genomics and Bioinformatics · 18
PDF
Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
2020 · Matthew Cannon, Hannah Phillips, et al. · Journal of Clinical Medicine · 13
PDF
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia
2021 · Janek S. Walker, Zachary A. Hing, et al. · Nature Communications · 11
PDF
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon Barcodes
2020 · Emily M. Teets, Charles Gregory, et al. · Scientific Reports · 5
PDF
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies
2025 · Nadeen Anabtawi, Deedra Nicolet, et al. · Leukemia · 4
PDF
VIP152 Is a Novel CDK9 Inhibitor with Efficacy in Chronic Lymphocytic Leukemia
2021 · Steven Sher, Larry Beaver, et al. · Blood · 3
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome
2020 · Caner Saygin, Karilyn Larkin, et al. · American Journal of Hematology · 3
PDF
Dysregulation of PRMT5 in Chronic Lymphocytic Leukemia Promotes Progression with High Risk of Richter's Transformation
2022 · Hing, Zachary, Walker, Janek, et al. · RePEc: Research Papers in Economics · 2
Rapid Molecular Diagnostics for Acute Myeloid Leukemia Using Single-Molecule Sequencing
2019 · Esko A. Kautto, Charles Thomas Gregory, et al. · Blood · 2
Abstract 2260: Evaluating a rare t(X;14)(q28;q32) translocation reveals MTCP1 as a driving factor in chronic lymphocytic leukemia
2021 · Janek S. Walker, Zachary A. Hing, et al. · Cancer Research · 1
NPM1 mutations Using Deep Amplicon Sequencing and Broad Next Generation Sequencing at the Time of Complete Remission Is Informative to Predicting Risk of Relapse Following Intensive Chemotherapy
2019 · Bhavana Bhatnagar, Shelley Orwick, et al. · Blood · 1
Abstract 3242: DNA methylation profiling of Epstein-Barr virus (EBV) in lymphoproliferative disease reveals diagnostic and therapeutic applications
2025 · Christoph Weigel, Haley L. Klimaszewski, et al. · Cancer Research
Methylome Analysis of Epstein-Barr Virus with Nanopore Sequencing Reveals Viral State Dynamics
2022 · Christoph Weigel, Esko Kautto, et al. · Blood
Dysregulation of PRMT5 in Chronic Lymphocytic Leukemia Supports Transformation to Diffuse Large B-Cell Lymphoma
2022 · Ethan Whipp, Zachary A Hing, et al. · Blood
Typesafe Coordinate Systems in High-Throughput Sequencing Applications
2022 · Gregory, Charles Thomas, Blachly, James S. · arXiv (Cornell University)
PDF
Enumerating Functional HSC Clones in the Zebrafish Using Gestalt
2019 · Emily M Teets, Charles Thomas Gregory, et al. · Blood
Works count: 21
Citation count: 398
H-index: 7
I10-index: 7
Year
Topic
Type